<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>539</volume><submitter>Zeng Y</submitter><funding>National Natural Science Foundation of China</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>Nucleic acid detection represents limitations due to its false-negative rate and technical complexity in the COVID-19 pandemic. Anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody tests are widely spread all over the world presently. However, there is no report on the effectiveness of anti-SARS-CoV-2 antibody testing methods in China.&lt;h4>Methods&lt;/h4>We gathered 10776 serum samples from close contacts of the SARS-CoV-2 infections in Fujian of China and used 2 chemiluminescence immunoassays (Wantai Bio., Yahuilong Bio.) and 2 lateral flow immunoassays (Lizhu Bio. and Dongfang Bio.) to perform the anti-SARS-CoV-2 antibody tests in China.&lt;h4>Results&lt;/h4>The 4 antibody tests have great diagnostic value for infected or uninfected, especially in the neutr</pubmed_abstract><journal>Clinica chimica acta; international journal of clinical chemistry</journal><pagination>237-243</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9783188</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Evaluating the value of anti-SARS-CoV-2 antibody detection and neutralizing responses with euvirus: A population of 10776 close contacts in the epidemic of Fujian.</pubmed_title><pmcid>PMC9783188</pmcid><pubmed_authors>Huang C</pubmed_authors><pubmed_authors>Li J</pubmed_authors><pubmed_authors>Zhang J</pubmed_authors><pubmed_authors>Wei D</pubmed_authors><pubmed_authors>Ji F</pubmed_authors><pubmed_authors>Xiao Y</pubmed_authors><pubmed_authors>Chen F</pubmed_authors><pubmed_authors>Zeng Y</pubmed_authors><pubmed_authors>Lin Z</pubmed_authors><pubmed_authors>Zhang L</pubmed_authors><pubmed_authors>Hong G</pubmed_authors><pubmed_authors>Huang L</pubmed_authors><pubmed_authors>Teng J</pubmed_authors><pubmed_authors>Tu H</pubmed_authors><pubmed_authors>Ou Q</pubmed_authors><pubmed_authors>Li Z</pubmed_authors><pubmed_authors>Lin C</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Cao Y</pubmed_authors><pubmed_authors>Wu S</pubmed_authors><pubmed_authors>Liu C</pubmed_authors><pubmed_authors>Yang T</pubmed_authors><pubmed_authors>Ye H</pubmed_authors><pubmed_authors>Chen T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Evaluating the value of anti-SARS-CoV-2 antibody detection and neutralizing responses with euvirus: A population of 10776 close contacts in the epidemic of Fujian.</name><description>&lt;h4>Background&lt;/h4>Nucleic acid detection represents limitations due to its false-negative rate and technical complexity in the COVID-19 pandemic. Anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody tests are widely spread all over the world presently. However, there is no report on the effectiveness of anti-SARS-CoV-2 antibody testing methods in China.&lt;h4>Methods&lt;/h4>We gathered 10776 serum samples from close contacts of the SARS-CoV-2 infections in Fujian of China and used 2 chemiluminescence immunoassays (Wantai Bio., Yahuilong Bio.) and 2 lateral flow immunoassays (Lizhu Bio. and Dongfang Bio.) to perform the anti-SARS-CoV-2 antibody tests in China.&lt;h4>Results&lt;/h4>The 4 antibody tests have great diagnostic value for infected or uninfected, especially in the neutr</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jan</publication><modification>2025-04-05T11:31:19.27Z</modification><creation>2025-02-18T22:53:03.033Z</creation></dates><accession>S-EPMC9783188</accession><cross_references><pubmed>36572136</pubmed><doi>10.1016/j.cca.2022.12.017</doi></cross_references></HashMap>